← All Disc Medicine, INC filings

Disc Medicine, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
IRON
Disc Medicine, INC
SCHEDULE: FMR LLC Reports 12.8% Stake in Disc Medicine
FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing, reporting a combined beneficial ownership of 12.8% in Disc Medicine Inc. as of June 30, 2026.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE: RA Capital Discloses 5.9% Stake in Disc Medicine
RA Capital Management and its affiliates have reported a 5.9% passive ownership stake in Disc Medicine, Inc., totaling 2,228,924 shares.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE: FMR LLC, Abigail Johnson Report 14.1% Disc Medicine Stake
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 14.1% in Disc Medicine Inc., totaling 4,907,158.99 common shares.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE: Frazier Life Sciences Amends DISC Medicine Stake Disclosure
Frazier Life Sciences and its affiliates filed an amended Schedule 13G, clarifying their beneficial ownership in DISC Medicine, Inc. and correcting prior attribution.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE: Wellington Management Discloses 4.1% Stake in Disc Medicine
Wellington Management Group and its affiliates reported a 4.1% beneficial ownership stake in Disc Medicine, Inc. as of June 30, 2025, holding 1,432,090 common shares.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE: FMR LLC Discloses 12.2% Stake in Disc Medicine
FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 12.2% in Disc Medicine Inc.'s common stock as of July 31, 2025.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE 13G/A: Paradigm BioCapital Entities Report Passive Stake in Disc Medicine, Inc.
Paradigm BioCapital Advisors LP, its general partner, and its managing member, along with Paradigm BioCapital International Fund Ltd., have filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.5% in Disc Medicine, Inc.'s common stock as of March 31, 2025.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE 13G: Wellington Management Entities Disclose 6.78% Stake in Disc Medicine, Inc.
Wellington Management Group LLP and its affiliates have filed a Schedule 13G, reporting beneficial ownership of 6.78% of Disc Medicine, Inc.'s common stock as of March 31, 2025.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Reaffirm 9.3% Stake in Disc Medicine Inc.
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, confirming their beneficial ownership of 9.3% of Disc Medicine Inc.'s common stock as of March 31, 2025.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE 13G/A: Bain Capital Life Sciences Maintains Significant Stake in Disc Medicine, Inc.
Bain Capital Life Sciences Opportunities III, LP has disclosed a continued beneficial ownership of 3.3% in Disc Medicine, Inc. as of December 31, 2024.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE 13G: FMR LLC and Abigail P. Johnson Disclose 6.3% Stake in Disc Medicine Inc.
FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting beneficial ownership of 6.3% of Disc Medicine Inc.'s common stock as of December 31, 2024.
NASDAQ
IRON
Disc Medicine, INC
SCHEDULE 13G/A: Wellington Management Discloses 4.7% Passive Stake in Disc Medicine
Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, disclosing a 4.7% beneficial ownership stake in Disc Medicine, Inc. as of December 31, 2024.